Some studies show that the occurrence of familial/early-onset AD, sporadic/late-onset AD, and patient’s cognitive decline are related to DKK1 and Wnt/β-catenin signaling disruptions (Scott and Brann, 2013). This evidence concerns the gene DKK1 and Alzheimer disease.